Back to search

Article

Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort study

2021-07-31

Abstract excerpt

<h4>Objectives</h4> Highly effective vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed but variants of concerns (VOCs) with mutations in the spike protein are worrisome, especially B.1.617.2 (Delta) which has rapidly spread across the world. We aim to study if vaccination alters virological and serological kinetics in breakthrough infections. <h4>Methods</h4> We cond...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0233acd2-b720-57a2-bee0-fa6ed4228a0d
DOI
10.1101/2021.07.28.21261295
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Virological and serological kinetics of SARS-CoV-2 Delta variant vaccine-breakthrough infections: a multi-center cohort studyDOI 10.1101/2021.07.28.21261295
Select a neighboring publication to make it the new centre.